Mycoplasma pneumoniae–associated flagellate erythema by Meyer Sauteur, Patrick M & Theiler, Martin








Mycoplasma pneumoniae–associated flagellate erythema
Meyer Sauteur, Patrick M ; Theiler, Martin
Abstract: We recently described mucocutaneous findings in pediatric patients with community-acquired
pneumonia caused by Mycoplasma pneumoniae,1 of whom 3 (6.8%) were diagnosed with M pneumoniae–
induced rash and mucositis (MIRM).2 ,3 We wish to describe another MIRM patient, who recently
presented with a unique clinical picture following the resolution of MIRM, which is, to our knowledge,
the first case of M pneumoniae–associated flagellate erythema.
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INTRODUCTION
We recently described mucocutaneous findings in
pediatric patients with community-acquired pneu-
monia caused by Mycoplasma pneumoniae,1 of
whom 3 (6.8%) were diagnosed with M pneumo-
niaeeinduced rash and mucositis (MIRM).2,3 We
wish to describe another MIRM patient, who recently
presented with a unique clinical picture following
the resolution of MIRM, which is, to our knowledge,
the first case ofM pneumoniaeeassociated flagellate
erythema.
CASE REPORT
A previously healthy 12-year-old boy was hospi-
talized for 2 weeks because of MIRM, characterized
by severe oral, ocular, and urogenital mucositis (Fig
1). Chest radiograph showed atypical pneumonia,
and test results for M pneumoniae were positive
from a pharyngeal swab sample by polymerase chain
reaction (PCR) and from a blood sample by serologic
testing (IgM[ 150 U/mL, cutoff 17 U/mL; IgG 23 U/
mL, cutoff 15 U/mL) (Virion/Serion). IgM antibody-
secreting cells were detected by enzyme-linked
immunospot assay.4,5 The patient was treated with
doxycycline (2 mg/kg, twice daily for 7 days),
methylprednisolone (3 mg/kg, once daily for
3 days), and supportive therapy.
After 4 weeks, when the patient had complete
resolution of his mucositis, he developed a peculiar
rash over the thorax and flank (Fig 2, A) and on the
back (Fig 2, B). Physical examination revealed par-
allel, erythematous, slightly purpuric streaks, consis-
tent with flagellate erythema. The lesions were
Fig 1. MIRM. MIRM, Mycoplasma pneumoniaeeinduced
rash and mucositis.
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neither painful nor pruritic and resolved after several
days with topical corticosteroid treatment. The
patient was always in a good general condition, had
no fever, denied scratching or any other trauma to the
skin, and did not take any medications or consume
shiitake mushrooms. Laboratory studies showed a
normal white blood cell count (7640/L) and
C-reactive protein level (\0.4 mg/L). Rheumatoid
factor and antinuclear antibodies were absent. Patch
testing result with the agents used for supportive
therapy during the MIRM episode was negative. M
pneumoniae was still detectable by PCR, and the
serologic testing results (IgM[150 U/mL, IgG 35 U/
mL) and enzyme-linked immunospot assay results for
IgM antibody-secreting cells remained positive.
Another episode of flagellate erythema on the
anterior aspect of the thorax occurred 3 months later
(Fig 3), at which time the serology was still positive
(IgM 130 U/mL, IgG 22 U/mL) but the results of PCR
and the enzyme-linked immunospot assay for IgM
antibody-secreting cells were negative. No recur-
rences have been observed since then.
DISCUSSION
Flagellate erythema is characterized by parallel,
linearly arranged lesions mainly located on the
back and shoulders6 and is very rarely observed in
children.7 The exact pathologic mechanism remains
unknown. The differential diagnosis of flagellate
erythema includes bleomycin treatment, dermato-
myositis, adult-onset Still disease, and consumption
of uncooked shiitake mushrooms.6-9 The ongoing
and pronounced specific immune response against
M pneumoniae at the onset of flagellate erythema
after the pulmonary infection supports a causal
Fig 2. Flagellate erythema on the thorax and flank (A) and on the back (B).
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relationship and is in line with the proposed
immune-mediated pathogenesis of M pneumo-
niaeeinduced mucocutaneous disease.1 This report
may add flagellate erythema to the diverse dermato-
logic manifestations associated with M pneumoniae.
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